Public Citizen demands removal of top FDA officials over Biogen Alzheimer's approval

Watchdog group Public Citizen is demanding the resignation of three top FDA officials, including Commissioner Janet Woodcock, over the agency's approval last week of Biogen's (NASDAQ:BIIB) Aduhelm (aducanumab) for Alzheimer's disease.